How is adenomyosis diagnosed in women of reproductive age presenting with heavy menstrual bleeding, pelvic pain, and an enlarged tender uterus?

Diagnosis of Adenomyosis

Adenomyosis is diagnosed primarily through transvaginal ultrasound (TVUS) as the first-line imaging modality, with MRI reserved for complex cases or when ultrasound is inconclusive. 1

Diagnostic Approach

Clinical Presentation

The diagnosis begins with recognizing the characteristic symptom triad, though one-third of patients are asymptomatic 2:

• Heavy menstrual bleeding (most common symptom)
• Pelvic pain (dysmenorrhea, dyspareunia, chronic pelvic pain)
• Infertility or reproductive dysfunction

On physical examination, look for an enlarged, tender, globular uterus on bimanual pelvic evaluation 1, 2.

Imaging Modalities

Transvaginal Ultrasound (First-Line)

TVUS is the initial diagnostic tool of choice due to its high specificity, accessibility, and cost-effectiveness 3, 1. Key ultrasound features include:

• Asymmetric myometrial thickening
• Heterogeneous myometrial echotexture
• Myometrial cysts
• Linear striations
• Subendometrial echogenic nodules or lines
• Globular uterine enlargement

Both 2D and 3D ultrasound can be utilized, with 3D potentially offering enhanced visualization 4.

MRI (Second-Line or Complementary)

MRI offers superior sensitivity, particularly for characterizing lesion subtypes and preoperative planning 3, 1. MRI is especially valuable when:

• Ultrasound findings are equivocal
• Coexisting pathology (fibroids, endometriosis) complicates the picture
• Precise lesion mapping is needed for surgical or interventional planning
• Distinguishing diffuse from focal adenomyosis is clinically important

MRI can identify:

• Junctional zone thickening (>12 mm is highly suggestive)
• High signal intensity myometrial foci on T2-weighted images
• Diffuse versus focal disease patterns
• Adenomyomas (focal lesions)

Integrated Diagnostic Strategy

The most effective approach combines clinical assessment with imaging findings 4. Consider:

1. Risk factor profile: Increasing age (typically 40-50 years, but younger patients with infertility increasingly diagnosed), multiparity, history of uterine procedures 2

2. Symptom phenotype: Bleeding-dominant, pain-dominant, or infertility-related presentation 5

3. Imaging phenotype: Diffuse versus focal disease, lesion location, coexisting pathology 6, 5

Important Caveats

Diagnostic Challenges

• No universally standardized diagnostic criteria exist across imaging modalities 7, 4
• Adenomyosis frequently coexists with endometriosis and uterine fibroids, complicating diagnosis 2, 6
• Histopathology remains the gold standard but requires hysterectomy, making it impractical for fertility-preserving management 1, 4
• Poor inter-observer reproducibility exists for limited/focal disease on histology 4

Practical Considerations

• Avoid relying solely on symptoms for diagnosis—they are heterogeneous and non-specific 4
• TVUS quality is operator-dependent; expertise in gynecologic imaging improves diagnostic accuracy
• MRI should not be routine but reserved for cases where it will change management 3
• Younger women with infertility are increasingly diagnosed due to improved imaging; maintain high clinical suspicion in this population 2

Diagnostic Algorithm

1. Clinical suspicion based on symptoms (heavy bleeding, pelvic pain) and examination (enlarged, tender uterus)
2. Transvaginal ultrasound as initial imaging
3. MRI if:
   • TVUS inconclusive
   • Complex coexisting pathology
   • Preoperative/pre-interventional planning needed
   • Precise lesion characterization required for treatment selection
4. Integrate findings with patient's reproductive goals and symptom severity to guide management

The shift from histopathological to imaging-based diagnosis represents a major advancement, enabling non-invasive diagnosis in reproductive-age women who wish to preserve fertility 4.